Ophthalmologic examinations

DIAGNOSTIC_TEST3 trials

Sponsors

Vertex Pharmaceuticals Incorporated, Holostem s.r.l., The First Affiliated Hospital of Zhengzhou University

Conditions

Cystic FibrosisHigh MyopiaLimbal Stem Cell Deficiency Due to Ocular Burn

Unknown Phase

An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis

CompletedNCT01863238

Vertex Pharmaceuticals IncorporatedCystic Fibrosis

Start: 2013-05-31End: 2016-05-31Updated: 2016-08-23

Follow-up Study After ACLSCT for Restoration of Corneal Epithelium in Patients With LSCD Due to Ocular Burns

CompletedNCT03288844

Holostem s.r.l.Limbal Stem Cell Deficiency Due to Ocular Burn

Start: 2017-12-13End: 2023-03-31Updated: 2023-05-26

Genetic Research on High Myopic Individuals in Northern China

CompletedNCT06204211

The First Affiliated Hospital of Zhengzhou UniversityHigh Myopia

Start: 2022-05-01End: 2023-08-31Updated: 2024-01-12

Related Papers

The association of ARR3 genetic polymorphisms with pathologic myopia in Northern Chinese population.

2025-10-09